CCL2 and type 2 diabetes mellitus: Additionally, miR-126 can target C-C Motif Chemokine Ligand 2 (CCL2) directly in inflammatory conditions and the overexpression of miR-126 can attenuate CCL2 production in human adipocytes cells, regulating the inflammatory process reducing insulin resistance and making it an interesting target for T2D treatment [94].